Transcode Therapeutics News

Transcode Therapeutics | 8-K: Current report

Sep 27 16:05 ET

Transcode Therapeutics | 8-K: Current report

Aug 28 06:09 ET

Transcode Therapeutics | 8-K: Current report

Aug 16 17:08 ET

Transcode Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 14 16:51 ET

Transcode Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-3i, LP(9.9%),3i Management LLC(9.9%), etc.

Jul 26 16:09 ET

Transcode Therapeutics | 8-K: Current report

Jul 24 09:04 ET

Transcode Therapeutics | 424B5: Prospectus

Jul 24 08:19 ET

Transcode Therapeutics | 424B5: Prospectus

Jul 22 16:13 ET

Transcode Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Thomas A. Fitzgerald(5.5%)

Jun 21 16:09 ET

Transcode Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Fitzgerald Thomas A

Jun 18 16:22 ET

Transcode Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Manting Erik

Jun 18 16:22 ET

Transcode Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Marquet Magda

Jun 18 16:21 ET

Transcode Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Calais Philippe

Jun 18 16:20 ET

Transcode Therapeutics | 8-K/A: Current report (Amendment)

Jun 14 08:04 ET

Transcode Therapeutics | 8-K: Current report

Jun 13 17:09 ET

Transcode Therapeutics | DEFA14A: Others

Jun 10 08:48 ET

Transcode Therapeutics | 8-K: Current report

Jun 7 16:03 ET

Transcode Therapeutics | DEFA14A: Others

Jun 7 16:03 ET

Transcode Therapeutics | DEFR14A: Definitive proxy statement in connection with contested solicitations

May 20 16:01 ET

Transcode Therapeutics | 10-Q: Q1 2024 Earnings Report

May 15 22:23 ET